These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9462241)

  • 1. Determination of proliferative activity in nasal polyps.
    Hassid S; Degaute MP; Dawance S; Rombaut K; Nagy N; Choufani G; Decaestecker C; Danguy A; Salmon I; Kiss R
    J Clin Pathol; 1997 Nov; 50(11):923-8. PubMed ID: 9462241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal polyposis pathogenesis: a flow cytometric and immunohistochemical study of epithelial cell proliferation.
    Coste A; Rateau JG; Bernaudin JF; Peynègre R; Escudier E
    Acta Otolaryngol; 1996 Sep; 116(5):755-61. PubMed ID: 8908256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image cytometry characterization of ploidy level, proliferative activity and chromatin pattern in 50 nasal polyps.
    Hassid S; Choufani G; Elkattabi O; Dawance S; Decaestecker C; Brugmans M; Danguy A; Pasteels J; Salmon I; Kiss R
    Int J Oncol; 1996 Jul; 9(1):137-43. PubMed ID: 21541493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology of nasal polyps of different etiology.
    Sorensen H; Mygind N; Tygstrup I; Winge Flensborg E
    Rhinology; 1977 Sep; 15(3):121-8. PubMed ID: 905718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal polyps in cystic fibrosis.
    Tos M; Mogensen C; Thomsen J
    J Laryngol Otol; 1977 Oct; 91(10):827-35. PubMed ID: 925492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
    Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
    Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased epithelial cell proliferation in nasal polyps.
    Coste A; Rateau JG; Roudot-Thoraval F; Chapelin C; Gilain L; Poron F; Peynegre R; Bernaudin JF; Escudier E
    Arch Otolaryngol Head Neck Surg; 1996 Apr; 122(4):432-6. PubMed ID: 8600930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algorithm analysis of lectin glycohistochemistry and Feulgen cytometry for a new classification of nasal polyposis.
    Hassid S; Decaestecker C; Hermans C; Salmon I; Pasteels JL; Danguy A; Kiss R
    Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1043-51. PubMed ID: 9415600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycohistochemical characteristics of nasal polyps from patients with and without cystic fibrosis.
    Hassid S; Choufani G; Decaestecker C; Delbrouck C; Dawance S; Pelc P; Nagy N; Kaltner H; Salmon I; Danguy A; Gabius HJ; Kiss R
    Arch Otolaryngol Head Neck Surg; 2000 Jun; 126(6):769-76. PubMed ID: 10864115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current aspects of diagnosis and therapy of nasal polyposis].
    Reiss M
    Wien Klin Wochenschr; 1997 Oct; 109(20):820-5. PubMed ID: 9454434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide induction of cyclooxygenase-2 in long-term nasal epithelial cultures in cystic fibrosis.
    Rozsasi A; Keck T
    Arch Otolaryngol Head Neck Surg; 2010 Apr; 136(4):335-9. PubMed ID: 20403848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polyposis of the nasal cavity and sinuses].
    Roessler F; Grossenbacher R
    Schweiz Med Wochenschr; 1987 Feb; 117(6):209-16. PubMed ID: 3563447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic rhinonsinusitis and nasal polyposis: the etiopathogenesis revealed?
    Van Cauwenberge P; Van Zele T; Bachert C
    Verh K Acad Geneeskd Belg; 2008; 70(5-6):305-22. PubMed ID: 19725391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
    Beer H; Southern KW; Swift AC
    Cochrane Database Syst Rev; 2011 May; (5):CD008253. PubMed ID: 21563167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.
    Rozsasi A; Heinemann A; Keck T
    Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiopathogenesis of nasal polyps.
    Krajina Z
    Acta Med Croatica; 1993; 47(2):81-4. PubMed ID: 7505133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial damage in nasal polyps.
    Wladislavosky-Waserman P; Kern EB; Holley KE; Eisenbrey AB; Gleich GJ
    Clin Allergy; 1984 May; 14(3):241-7. PubMed ID: 6733889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.
    Derycke L; Zhang N; Holtappels G; Dutré T; Bachert C
    J Cyst Fibros; 2012 May; 11(3):193-200. PubMed ID: 22178076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
    Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
    Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation on the expression of microvessel pericyte coverage index and lymph vessel density in nasal polyps].
    Cui N; Zhu DD; Guan GM; Sha JC; Meng CD; Li L; Xiu Q
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):923-928. PubMed ID: 27978883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.